Frontiers in Oncology | Thoracic Oncology

Clinical Trial

Published on 09 Sep 2021

Perioperative Outcome of Robotic Approach Versus Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study)

in Thoracic Oncology

Giulia Veronesi
Abbas El-Sayed Abbas
Piergiorgio Muriana
Rosalba Lembo
Edoardo Bottoni
Gianluca Perroni
Alberto Testori
Elisa Dieci
Charles T. Bakhos
Shamus Car

Frontiers in Oncology

doi 10.3389/fonc.2021.726408

8,385 views
97 citations

Original Research

Published on 09 Sep 2021

Prevalence of Delta-Like Protein 3 in a Consecutive Series of Surgically Resected Lung Neuroendocrine Neoplasms

in Thoracic Oncology

Greta Alì
Iosè Di Stefano
Anello Marcello Poma
Stefano Ricci
Agnese Proietti
Federico Davini
Marco Lucchi
Franca Melfi
Gabriella Fontanini

Frontiers in Oncology

doi 10.3389/fonc.2021.729765

7,315 views
22 citations

Original Research

Published on 08 Sep 2021

Development and Validation of a 18F-FDG PET-Based Radiomic Model for Evaluating Hypermetabolic Mediastinal–Hilar Lymph Nodes in Non-Small-Cell Lung Cancer

in Thoracic Oncology

Ming-li Ouyang
Yi-ran Wang
Qing-shan Deng
Ye-fei Zhu
Zhen-hua Zhao
Ling Wang
Liang-xing Wang
Kun Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.710909

4,998 views
20 citations

Original Research

Published on 08 Sep 2021

Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis

in Thoracic Oncology

Yiming Qi
Shuangshuang Wu
Linghui Tao
Yunfu Shi
Wenjuan Yang
Lina Zhou
Bo Zhang
Jing Li

Frontiers in Oncology

doi 10.3389/fonc.2021.683282

4,227 views
14 citations

Clinical Trial

Published on 08 Sep 2021

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

in Thoracic Oncology

Chul Kim
Stephen V. Liu
Jennifer Crawford
Tisdrey Torres
Vincent Chen
Jillian Thompson
Ming Tan
Giuseppe Esposito
Deepa S. Subramaniam
Giuseppe Giaccone

Frontiers in Oncology

doi 10.3389/fonc.2021.728155

7,216 views
24 citations

Original Research

Published on 08 Sep 2021

Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity

in Thoracic Oncology

Pengfei Zhang
Boxue He
Qidong Cai
Guangxu Tu
Xiong Peng
Zhenyu Zhao
Weilin Peng
Fenglei Yu
Min Wang
Yongguang Tao

Frontiers in Oncology

doi 10.3389/fonc.2021.705888

6,823 views
7 citations

Original Research

Published on 08 Sep 2021

Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients

in Thoracic Oncology

Naixin Liang
Lei Liu
Cheng Huang
Hongsheng Liu
Chao Guo
Ji Li
Weiwei Wang
Nan Li
Rui Lin
Tao Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.647512

7,045 views
10 citations

Systematic Review

Published on 07 Sep 2021

The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

in Thoracic Oncology

Yangyang Xu
Qin Wang
Jingyuan Xie
Mo Chen
Hongbing Liu
Ping Zhan
Tangfeng Lv
Yong Song

Frontiers in Oncology

doi 10.3389/fonc.2021.732214

7,699 views
26 citations

Original Research

Published on 07 Sep 2021

Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

in Thoracic Oncology

Rong Chai
Yipengchen Yin
Xuwei Cai
Xiaolong Fu
Qin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.724722

4,415 views
9 citations

Correction

Published on 07 Sep 2021

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

in Thoracic Oncology

Guotao Yin
Ziyang Wang
Yingchao Song
Xiaofeng Li
Yiwen Chen
Lei Zhu
Qian Su
Dong Dai
Wengui Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.747316

2,329 views
4 citations

Clinical Trial

Published on 06 Sep 2021

Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

in Thoracic Oncology

Mark M. Awad
Yvan Le Bruchec
Brian Lu
Jason Ye
JulieAnn Miller
Patrick H. Lizotte
Megan E. Cavanaugh
Amanda J. Rode
Calin Dan Dumitru
Alexander Spira

Frontiers in Oncology

doi 10.3389/fonc.2021.696512

7,519 views
40 citations

Original Research

Published on 06 Sep 2021

DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma

in Thoracic Oncology

Didi Yuan
Zehong Wei
Yicheng Wang
Fang Cheng
Yujie Zeng
Li Yang
Shangyu Zhang
Jianbo Li
Renkuan Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.734873

4,202 views
7 citations

Original Research

Published on 02 Sep 2021

EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes

in Thoracic Oncology

Haiyan Xu
Guangjian Yang
Weihua Li
Junling Li
Xuezhi Hao
Puyuan Xing
Yaning Yang
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.713483

25,307 views
18 citations

Original Research

Published on 01 Sep 2021

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection

in Thoracic Oncology

Yu-Jia Shen
Li-Qiang Qian
Zheng-Ping Ding
Qing-Quan Luo
Heng Zhao
Wu-Yan Xia
Yuan-Yuan Fu
Wen Feng
Qin Zhang
Wen Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.711206

4,783 views
33 citations

Mini Review

Published on 31 Aug 2021

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

in Thoracic Oncology

Clemence Demerlé
Laurent Gorvel
Daniel Olive

Frontiers in Oncology

doi 10.3389/fonc.2021.682007

10,286 views
63 citations

Original Research

Published on 30 Aug 2021

Pulmonary Neuroendocrine Neoplasms Overexpressing Epithelial-Mesenchymal Transition Mechanical Barriers Genes Lack Immune-Suppressive Response and Present an Increased Risk of Metastasis

in Thoracic Oncology

Tabatha Gutierrez Prieto
Camila Machado Baldavira
Juliana Machado-Rugolo
Cecília Farhat
Eloisa Helena Ribeiro Olivieri
Vanessa Karen de Sá
Eduardo Caetano Abilio da Silva
Marcelo Luiz Balancin
Alexandre Muxfeldt Ab´Saber
Teresa Yae Takagaki

Frontiers in Oncology

doi 10.3389/fonc.2021.645623

7,205 views
13 citations

Original Research

Published on 27 Aug 2021

Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer

in Thoracic Oncology

Lian Yu
Jianlin Xu
Rong Qiao
Hua Zhong
Baohui Han
Runbo Zhong

Frontiers in Oncology

doi 10.3389/fonc.2021.675354

4,906 views
5 citations

Review

Published on 27 Aug 2021

Management of Large Cell Neuroendocrine Carcinoma

in Thoracic Oncology

Virginia Corbett
Susanne Arnold
Lowell Anthony
Aman Chauhan

Frontiers in Oncology

doi 10.3389/fonc.2021.653162

68,612 views
43 citations

Original Research

Published on 23 Aug 2021

Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Wenhua Zhao
Wei Jiang
Huilin Wang
Jianbo He
Cuiyun Su
Qitao Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.703143

11,064 views
61 citations

Mini Review

Published on 23 Aug 2021

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue

in Thoracic Oncology

Shinkichi Takamori
Taichi Matsubara
Naoki Haratake
Gouji Toyokawa
Takatoshi Fujishita
Ryo Toyozawa
Kensaku Ito
Masafumi Yamaguchi
Kenichi Taguchi
Tatsuro Okamoto

Frontiers in Oncology

doi 10.3389/fonc.2021.704084

11,079 views
15 citations

Review

Published on 19 Aug 2021

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy

in Thoracic Oncology

Xiangjun Liu
Ye Cheng
Dan Zang
Min Zhang
Xiuhua Li
Dan Liu
Bing Gao
Huan Zhou
Jinzhe Sun
Xu Han

Frontiers in Oncology

doi 10.3389/fonc.2021.720842

22,113 views
105 citations

Mini Review

Published on 18 Aug 2021

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

in Thoracic Oncology

Wei Xiong
Yunfeng Zhao
He Du
Xuejun Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.704336

12,562 views
48 citations

Original Research

Published on 17 Aug 2021

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2–Jagged1 Interaction in Lung Cancer

in Thoracic Oncology

Ying-Ming Tsai
Kuan-Li Wu
Yu-Wei Liu
Wei-An Chang
Yung-Chi Huang
Chao-Yuan Chang
Pei-Hsun Tsai
Szi-Hui Liao
Jen-Yu Hung
Ya-Ling Hsu

Frontiers in Oncology

doi 10.3389/fonc.2021.696931

7,486 views
27 citations

Original Research

Published on 16 Aug 2021

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations

in Thoracic Oncology

Zhengyu Yang
Ya Chen
Yanan Wang
Shuyuan Wang
Minjuan Hu
Bo Zhang
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.681429

4,686 views
20 citations

1,969 articles

articles

Perioperative Outcome of Robotic Approach Versus Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study)

Prevalence of Delta-Like Protein 3 in a Consecutive Series of Surgically Resected Lung Neuroendocrine Neoplasms

Development and Validation of a 18F-FDG PET-Based Radiomic Model for Evaluating Hypermetabolic Mediastinal–Hilar Lymph Nodes in Non-Small-Cell Lung Cancer

Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity

Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients

The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma

EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer

Pulmonary Neuroendocrine Neoplasms Overexpressing Epithelial-Mesenchymal Transition Mechanical Barriers Genes Lack Immune-Suppressive Response and Present an Increased Risk of Metastasis

Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung Cancer

Management of Large Cell Neuroendocrine Carcinoma

Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2–Jagged1 Interaction in Lung Cancer

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations